View abstract

Cet abstract a été assigné à sessions

Type de présentation	E-poster
Titre	Treatment of Metastatic Uveal Melanoma

But	Description of the various treatments and follow-up of metastatic uveal melanoma patients. Assesment whether the introduction of immune checkpoint inhibitors improved survival.
Méthodes	retrospective single-center study.
Résultats	121 metastatic uveal melanoma patients were registered. No significant improvement of the survival could be established after the introduction of immune checkpoint inhibitors. Only liver-directed and local oligometastatic approaches were associated with a lower chance of mortality when compared tot immune checkpoint inhibitors (p=0.0025).
Conclusion	Although we documented responses tot immune checkpoint inhibitors, our analyses do not demonstrate an overall survival improvement of checkpoint inhibitors over alternative treatment strategies. However, local treatment options, whether liver-directed or for oligometastatic disease, may be beneficial and should be considerd.
Conflit d'intérêt	Non

Auteur 1

Nom	MISSOTTEN
Initiales	G
Institut	Jessa Oogkliniek Hasselt and University Hospitals Leuven
Ville	Hasselt/Leuven

Auteur 2

Nom	Vanaken
Initiales	L
Institut	Department of Oncology, University Hospitals Leuven
Ville	Leuven

Auteur 3

Nom	Van Ginderdeuren
Initiales	R
Institut	Department of ophthalmology, University Hospitals Leuven
Ville	Leuven

Auteur 4

Nom	Thal
Initiales	D
Institut	Department of Pathology, University Hospitals Leuven
Ville	Leuven

Auteur 5

Nom	Bechter
Initiales	O
Institut	Department of Oncology, University Hospitals Leuven
Ville	Leuven

Auteur 6

Nom	Clement
Initiales	P
Institut	Department of Oncology, University Hospitals Leuven
Ville	Leuven